A test being developed by researchers at Stanford University and Enable Biosciences could be used for HIV screening sooner than traditional immunoassays.
Its CEO said that although a hospital screening test for sepsis is a focus, a fever test that informs about antibiotic use could be available sooner.
The funding will support further development of an existing serum-based assay and expansion of the test to use saliva samples.
The funding will be used to support the the newly established ME/CFS Collaborative Research Center at Stanford University.
The team has developed a method to test for inherited disorders prenatally and plan to conduct a larger trial and eventually offer it as a clinical test.
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
Inflammatix hopes to market an 18-gene panel that will be able to tell from a blood sample whether a hospitalized patient has a bacterial, viral, or no infection.
The test from Qiagen was able to identify young children with high interferon-gamma levels who later developed active disease.
Following validation, the approach, which uses a deep convolutional neural network trained with almost 130,000 clinical images, could be developed into a smartphone app to detect skin cancer early.
Stanford researchers showed that wearables could identify inflammation, insulin resistance, and the onset of infection.